Health Care & Life Sciences » Biotechnology | Gene Techno Science Co. Ltd.

Gene Techno Science Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
1,610
887
817
2,380
1,891
2,009
Total Accounts Receivable
149
17
199
587
405
559
Inventories
-
5
-
-
-
12
Other Current Assets
123
10
504
455
396
241
Total Current Assets
1,882
919
1,520
3,422
2,692
2,822
Net Property, Plant & Equipment
1
1
2
2
2
1
Total Investments and Advances
4
2
171
282
325
323
Intangible Assets
-
-
-
-
-
-
Other Assets
-
-
-
-
6
6
Total Assets
1,887
922
1,694
3,706
3,025
3,151
ST Debt & Current Portion LT Debt
-
-
810
-
-
Accounts Payable
-
-
69
-
60
Income Tax Payable
6
7
8
27
2
Other Current Liabilities
44
18
392
162
343
Total Current Liabilities
50
25
1,280
189
405
Long-Term Debt
775
-
-
-
-
Provision for Risks & Charges
9
10
11
15
15
Deferred Taxes
-
-
-
2
1
Total Liabilities
834
34
1,291
206
421
Common Equity (Total)
1,053
888
403
3,500
2,604
Total Shareholders' Equity
1,053
888
403
3,500
2,604
Total Equity
1,053
888
403
3,500
2,604
Liabilities & Shareholders' Equity
1,887
922
1,694
3,706
3,025

About Gene Techno Science Co.

View Profile
Address
Wall Annex 502
Sapporo Hokkaido 060
Japan
Employees -
Website http://www.g-gts.com
Updated 07/08/2019
Gene Techno Science Co., Ltd. engages in the research and development of biopharmaceutical products. Its products include antibodies, oligosaccharides, small interfering ribonucleic acids, proteins, and peptides. The company was founded on March 1, 2001 and is headquartered in Sapporo, Japan.